TRIM25 and hepatocellular carcinoma: In this study, human HBV-related HCC tissues and HepG2.2.15 cells were used as research objects to explore the molecular mechanism of lncRNA XIST, miR-192, and TRIM25 in HBV-related HCC, aiming to provide a theoretical basis for targeted treatment of HBV-related HCC.